½ÃÀ庸°í¼­
»óǰÄÚµå
1306534

¼¼°èÀÇ Ã´¼ö Àڱر⠽ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)

Global Spinal Cord Stimulation Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 128 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ô¼ö Àڱر⠽ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2022³â 29¾ï 8,000¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 61¾ï 2,000¸¸ ´Þ·¯¿¡ °¡±î¿î ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 2023-2030³âÀÇ Á¶»ç ±â°£ µ¿¾È 9.4%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ô¼ö Àڱرâ´Â ƯÈ÷ ´Ù¸¥ Ä¡·á¹ýÀÌ È¿°úÀûÀÌÁö ¾ÊÀ» ¶§ ¸¸¼º ÅëÁõ »óŸ¦ °ü¸®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á¿ë ÀÓÇöõÆ®ÀÔ´Ï´Ù. ÀÌ ÀåÄ¡´Â ô¼ö¿¡ Àü±â ÀÚ±ØÀ» °ø±ÞÇÏ¿© ³ú¿¡ µµ´ÞÇϱâ Àü¿¡ ÅëÁõ ½ÅÈ£¸¦ Á¶ÀýÇϰųª Â÷´ÜÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â Àü±â ÀÚ±ØÀ» °ø±ÞÇÏ¿© ÀÛµ¿ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ :

ôÃß ¼ö¼ú ÈÄ ÅëÁõ ÁõÈıº ¹× ½Å°æº´Áõ¼º ÅëÁõ°ú °°Àº ¸¸¼º ÅëÁõ ÁúȯÀÇ À¯º´·ü Áõ°¡´Â È¿°úÀûÀÎ ÅëÁõ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃŰ´Â ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ôÃß ÀÚ±Ø Ä¡·á¿¡ ´ëÇÑ È¯ÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üÀÇ Àνİú ¼ö¿ëµµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀåÀ» ´õ¿í °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀåºñÀÇ ±â´ÉÀÌ °³¼±µÇ¾î ȯÀÚÀÇ Æí¾ÈÇÔ°ú ÅëÁõ °ü¸® °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ¿ÀÇÇ¿ÀÀÌµå »ç¿ëÀ» ÁÙÀÌ°í ¿ÀÇÇ¿ÀÀ̵å À§±â¿¡ ´ëóÇÏ´Â µ¥ ÁßÁ¡À» µÎ°í ÀÖ´Â °¡¿îµ¥, ÀÌ·¯ÇÑ ±â±â´Â ºñ¾à¸®ÇÐÀû ´ë¾ÈÀ» Á¦°øÇÔÀ¸·Î½á ¸Å·ÂÀûÀÎ ´ë¾ÈÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. °í·ÉÈ­ »çȸµµ ½ÃÀå ¼ö¿ä¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¸¸¼º ÅëÁõÀº ³ëÀε鿡°Ô¼­ ¸¹ÀÌ ¹ß°ßµÇ±â ¶§¹®ÀÔ´Ï´Ù. ô¼öÀڱؿä¹ý¿¡ ´ëÇÑ ¿ìÈ£ÀûÀÎ »óȯ Á¤Ã¥°ú º¸Çè Àû¿ëÀº ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ Ä¡·á ¿É¼ÇÀ¸·Î ô¼öÀڱؿä¹ýÀ» Á¦°øÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ôÃß Àڱرâ´Â ÅëÁõÀ» ¿ÏÈ­ÇÏ°í ¾à¹° ÀÇÁ¸µµ¸¦ ³·Ãß¸ç ±â´ÉÀû ´É·ÂÀ» Çâ»ó½Ãų ¼ö Àֱ⠶§¹®¿¡ »îÀÇ ÁúÀ» Çâ»ó½Ã۰íÀÚ Çϴ ȯÀÚµéÀÇ ¼±È£µµ°¡ ôÃß Àڱر⿡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â Portre's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, °¡Ä¡»ç½½ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¼¼°è ô¼ö Àڱر⠽ÃÀåÀÇ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ô¼ö Àڱر⠻ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀºÀÌ ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ªº° ºÐ¼® :

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ã´¼ö Àڱر⠽ÃÀåÀÇ ÇöÀç¿Í ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¶ÇÇÑ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϰú ¼¼°è °æÀï ±¸µµ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ °ßÇØ¸¦ ´Ù·ì´Ï´Ù. ôÃß Àڱر⠽ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Boston Scientific Corporation, St. Jude Medical, Inc,(Abbott), Neurosigma Inc, NeuroSigma Inc, Nevro Corp, Synapse Biomedical Inc, Medtronic µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ ¼½¼ÇÀº ÁÖ¿ä ÀμöÇÕº´, ¹Ì·¡ ¿ª·®, ÆÄÆ®³Ê½Ê, À繫 °³¿ä, Çù¾÷, ½ÅÁ¦Ç° °³¹ß, ½ÅÁ¦Ç° Ãâ½Ã¿Í °°Àº ´Ù¾çÇÑ Àü·«Àû ¹ßÀüÀ» Æ÷ÇÔÇÑ °æÀï ȯ°æÀÇ Àü¹ÝÀûÀÎ °³¿ä·Î ±¸¼ºµÅ ÀÖ½À´Ï´Ù.

¿äûÀÌ ÀÖÀ¸½Ã¸é ÀúÈñ¿¡°Ô ¿¬¶ôÇØ ÁֽʽÿÀ. ´ç»çÀÇ Á¶»ç ÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇüÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ô¼ö Àڱرâ - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ Ã´¼ö Àڱر⠽ÃÀå ºÐ¼® : Á¦Ç°º°

  • Á¦Ç°º° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • Á¦Ç°º° ºÐ¼®
  • ÃæÀü½Ä
  • ºñÃæÀü½Ä

Á¦6Àå ¼¼°èÀÇ Ã´¼ö Àڱر⠽ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ¿ëµµº°
  • FBS(ôÃß ¼ö¼ú ÈÄ ÅëÁõ ÁõÈıº)
  • º¹ÇÕºÎÀ§ ÅëÁõ ÁõÈıº
  • µð½ºÅ© ÅðÇ༺ Áúȯ
  • µð½ºÅ© ¼ö¼ú ½ÇÆÐ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Ã´¼ö Àڱر⠽ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå ô¼ö Àڱر⠱â¾÷ÀÇ °æÀï ±¸µµ

  • ô¼ö Àڱر⠽ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦9Àå ±â¾÷ °³¿ä

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Boston Scientific Corporation
  • St. Jude Medical Inc(Abbott)
  • Neurosigma Inc
  • Nevro Corp
  • Synapse Biomedical Inc
  • Medtronic

Âü°í - ±â¾÷ ÇÁ·ÎÆÄÀϸµ¿¡¼­ À繫 ¼¼ºÎ Á¤º¸ ¹× ÃÖ±Ù °³¹ß ÇöȲÀº ÀÌ¿ë °¡´É ¿©ºÎ¿¡ µû¶ó ´Þ¶óÁö°Å³ª ºñ°ø°³ ȸ»çÀÇ °æ¿ì ´Ù·çÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.

LSH 23.08.23

The global demand for Spinal Cord Stimulation Devices Market is presumed to reach the market size of nearly USD 6.12 BN by 2030 from USD 2.98 BN in 2022 with a CAGR of 9.4% under the study period 2023 - 2030.

Spinal cord stimulation devices are medical implants used to manage chronic pain conditions, particularly when other treatments have been ineffective. These devices work by delivering electrical impulses to the spinal cord, which helps in modulating or blocking pain signals before reaching the brain.

MARKET DYNAMICS:

The rising prevalence of chronic pain conditions, such as failed back surgery syndrome and neuropathic pain, contributes to the demand for effective pain management solutions. These devices are recognised as a viable treatment option for these conditions. sA growing awareness and acceptance of spinal cord stimulation therapy among patients and healthcare providers is further driving the market. Technological advancements have improved device features, enhancing patient comfort and pain management outcomes. As the focus on reducing opioid use and addressing the opioid crisis increases, these devices offer a non-pharmacological alternative, making them an attractive option. The ageing population also significantly drives market demand, as chronic pain conditions are more prevalent among older adults. Favourable reimbursement policies and coverage for spinal cord stimulation therapy positively impact the market, encouraging healthcare providers to offer these devices as a treatment option. Furthermore, patient preferences for improved quality of life drive the demand for spinal cord stimulation devices, as they can provide pain relief, reduce medication dependency, and enhance functional abilities.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of spinal cord stimulation devices. The growth and trends of spinal cord stimulation devices industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the spinal cord stimulation devices market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Rechargeable
  • Non-Rechargeable

By Application

  • Failed Back Syndrome
  • Complex Regional Pain Syndrome
  • Degenerative Disk Disease
  • Unsuccessful Disk Surgery
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Spinal Cord Stimulation Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the spinal cord stimulation devices market include Boston Scientific Corporation, St. Jude Medical, Inc, (Abbott), Neurosigma Inc, Nevro Corp, Synapse Biomedical Inc, Medtronic. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SPINAL CORD STIMULATION DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SPINAL CORD STIMULATION DEVICES MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Rechargeable Historic and Forecast Sales by Regions
  • 5.5 Non-Rechargeable Historic and Forecast Sales by Regions

6 . GLOBAL SPINAL CORD STIMULATION DEVICES MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Failed Back Syndrome Historic and Forecast Sales by Regions
  • 6.5 Complex Regional Pain Syndrome Historic and Forecast Sales by Regions
  • 6.6 Degenerative Disk Disease Historic and Forecast Sales by Regions
  • 6.7 Unsuccessful Disk Surgery Historic and Forecast Sales by Regions
  • 6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL SPINAL CORD STIMULATION DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE SPINAL CORD STIMULATION DEVICES COMPANIES

  • 8.1. Spinal Cord Stimulation Devices Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF SPINAL CORD STIMULATION DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Boston Scientific Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. St. Jude Medical Inc (Abbott)
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Neurosigma Inc
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Nevro Corp
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Synapse Biomedical Inc
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Medtronic
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦